Slide 1: Q1 2021 Earnings Presentation
Q1 2021 Earnings Presentation May 6
Slide 2: Cautionary Statement
Cautionary Statement This presentation contains non-IFRS measures and forward-looking statements, including a discussion of our business targets, expectations, and outlook. We caution readers not to place undue reliance on our forward-looking statements Q1 2021 since a number of factors could cause
Slide 3: Executing our strategy
Executing our strategy Adjusted Adjusted EBITDA Diluted EPS Margin $0.50 14.7% 2% year-over-year increase in Adjusted EBITDA margin increased to adjusted diluted EPS 14.7% from 14.6% in Q1 2020 Q1 2021 Net Revenue Backlog $879M $4.6B 8% year-over-year decrease in revenue Backlog grew organically by
Slide 4: United States Q1 2021
United States Gross and net revenue ($ millions) Backlog $2.6 Billion Q1 2021 Gross Revenue Net Revenue Q1 Project Wins • Healthcare lab replacement and refurbishment California • Electrical grid maintenance and upgrades California – multiple clients • Effluent Limitation Design South Carolina Denve
Slide 5: Canada Q1 2021
Canada Gross and net revenue ($ millions) Backlog $1.2 Billion Q1 2021 Gross Revenue Net Revenue Q1 Project Wins • Cariboo Memorial Hospital Redevelopment Williams Lake, British Columbia • Queens Quay East Extension & Waterfront E LRT Toronto, Ontario • Westside Irrigation Project Saskatchewan's lar
Slide 6: Global Q1 2021
Global Gross and net revenue ($ millions) Backlog $0.8 Billion Q1 2021 Gross Revenue Net Revenue Q1 Project Wins • 9 Dam Safety Reviews Dunedin, New Zealand • Edith Cowan University City Campus façade design and buildings services engineering – Perth, Western Australia • Otaki to North Levin express
Slide 7: Q1 2021 Financial Performance
Q1 2021 Q1 2021 Financial Performance Theresa Jang - Executive Vice President and Chief Financial Officer 7
Slide 8: Q1 2021 results
Q1 2021 results Adjusted EBITDA and margin ($ millions, %) Q1 2021 Q1 2020 Change % Year- (In millions of Canadian dollars, except per share over-year amounts and percentages) $ $ change Net revenue 878.7 955.2 (8.0) Gross margin 466.4 506.7 (8.0) Administrative and marketing expenses 341.5 367.3 (7
Slide 9: Balance sheet strength
Balance sheet strength Net debt to adjusted EBITDA(1) 0.8x at March 31, 2021 Target range 1.0 - 2.0x Q1 2021 Days sales outstanding 75 days at March 31, 2021 Target 90 days (1) Net debt to adjusted EBITDA and days sales outstanding are non-IFRS measures discussed in the Definitions section 9 of this
Slide 10: Liquidity and capital allocation
Liquidity and capital allocation Quarterly and TTM free cash flow(1) ($ millions) (Comparisons to Q1 2020) • $99 million increase in free cash flow(1) • 13% decrease in capital expenditures $14 • ~$800 million in undrawn credit capacity Q1 2021 Capital returned to shareholders Cash flow from continu
Slide 11: Sustainable Progress
Sustainable Progress Q1 2021 11
Slide 12: Q&A
12 Q1 2021 Q&A